Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 60

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 60
---
 for ADSs/ordinary shares) during the offering. We cannot advise you as to whether the Selling Shareholders will in fact sell any or all of their ADSs/ordinary shares. In addition, the Selling Shareholders may sell, transfer or otherwise dispose of, at any time and from time to time, the ADSs/

41

TABLE OF CONTENTS

ordinary shares in transactions exempt from the registration requirements of the Securities Act after the date for which the information set forth in the table above is provided. However, for purposes of this table, we have assumed that none of the ADSs/ordinary shares covered by this prospectus will be held by the Selling Shareholders.

(4)

Consists of (i) 875,000 ADSs/ordinary shares purchased by RA Capital Healthcare Fund, L.P. (“RA Capital Healthcare Fund”) in the 2025 September PIPE and (ii) 875,000 ADSs/ordinary shares issuable upon the exercise of Warrants purchased by RA Capital Healthcare Fund in the 2025 September PIPE. RA Capital Management, L.P. is the investment manager for RA Capital Healthcare Fund. The general partner of RA Capital Management, L.P. is RA Capital Management GP, LLC, of which Peter Kolchinsky and Rajeev Shah are the managing members. Each of RA Capital Management, L.P., RA Capital Management GP, LLC, Mr. Kolchinsky and Mr. Shah may be deemed to have voting and investment power over the ADSs/ordinary shares held by RA Capital Healthcare Fund. RA Capital Management, L.P., RA Capital Management GP, LLC, Mr. Kolchinsky and Mr. Shah disclaim beneficial ownership of such ADSs/ordinary shares, except to the extent of any pecuniary interest therein. The principal business address of the persons and entities listed above is 200 Berkeley Street, 18th Floor, Boston, MA 02116.

(5)

Consists of (a) (i) 166,100 ADSs/ordinary shares purchased by RTW Master Fund, Ltd. in the 2025 September PIPE and (ii) 166,100 ADSs/ordinary shares issuable upon the exercise of Warrants purchased by RTW Master Fund, Ltd. in the 2025 September PIPE, (b) (i) 133,351 ADSs/ordinary shares purchased by RTW Innovation Master Fund, Ltd. in the 2025 September PIPE and (ii) 133,351 ADSs/ ordinary shares issuable upon the